A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus

Clinical trial NCT05104840 · TERMINATED

Trial details

NCT number: NCT05104840
Sponsor: Center Trials & Treatment
Status: TERMINATED
Study type: OBSERVATIONAL

COVID-19 SARS-CoV-2 Furin RGMc Processing Paired Basic Amino Acid Cleaving Enzyme (PACE)

Start date: 2022-08-10
Primary completion: 2023-03-27
Enrollment: 2432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.